Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Teva
Merck
Chubb
Chinese Patent Office
Cipla
Mallinckrodt
UBS
Dow
US Army

Generated: February 21, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,149,694

« Back to Dashboard

Summary for Patent: 5,149,694
Title: Combination of tobramycin and dexamethasone for topical ophthalmic use
Abstract:Disclosed are pharmaceutical compositions comprising tobramycin and dexamethasone for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for infection and control of inflammatory response for optimal wound healing and normalization of the eye.
Inventor(s): Cagle; Gerald D. (Fort Worth, TX), McDonald; Thomas O. (Fort Worth, TX), Rosenthal; Allan L. (Fort Worth, TX)
Assignee: Alcon Laboratories, Inc. (Fort Worth, TX)
Application Number:07/440,546
Patent Claims: 1. A method of treating ophthalmic inflammation and infection which comprises administering topically to the affected eye of a human host a therapeutically effective amount of an ophthalmic pharmaceutical composition comprising an anti-inflammatory effective amount of dexamethasone; and anti-infective effective amount of tobramycin; and a pharmaceutically acceptable carrier therefor.

2. A method according to claim 1, wherein the combined concentration of the tobramycin and the dexamethasone is 0.01 to 2.0 percent by weight, and the ratio of the amount of tobramycin to the amount of dexamethasone is in the range of from 0.1:1.0 to 10.0:1.0.

3. A method according to claim 1, wherein the concentration of the tobramycin is 0.3 percent by weight and the concentration of the dexamethasone is 0.1 percent by weight.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKinsey
Cerilliant
Daiichi Sankyo
Chinese Patent Office
QuintilesIMS
US Army
Cantor Fitzgerald
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot